Cargando…

Structure-based development of human antibody cocktails against SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Wang, Nan, Sun, Yao, Feng, Rui, Wang, Yuxi, Guo, Yan, Zhang, Li, Deng, Yong-Qiang, Wang, Lei, Cui, Zhen, Cao, Lei, Zhang, Yan-Jun, Li, Weimin, Zhu, Feng-Cai, Qin, Cheng-Feng, Wang, Xiangxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705432/ https://www.ncbi.nlm.nih.gov/pubmed/33262454 http://dx.doi.org/10.1038/s41422-020-00446-w

Ejemplares similares

Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms
por: Sun, Yao, et al.
Publicado: (2021)

Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection
por: Yao, Hangping, et al.
Publicado: (2020)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2
por: Zhang, Li, et al.
Publicado: (2021)

A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters
por: Li, Xiao-Feng, et al.
Publicado: (2022)

Potent neutralizing RBD‐specific antibody cocktail against SARS‐CoV‐2 and its mutant
por: Jia, Lina, et al.
Publicado: (2021)

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020)

Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
por: Qu, Yuanyuan, et al.
Publicado: (2021)

An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2
por: Sun, Chunyun, et al.
Publicado: (2022)

Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktails
por: Ma, Hang, et al.
Publicado: (2023)

hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants
por: Liu, Junli, et al.
Publicado: (2021)

The efficacy of a “cocktail therapy” on Parkinson’s disease with dementia
por: Zhang, Chenhao, et al.
Publicado: (2019)

Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes
por: Wang, Shuren, et al.
Publicado: (2022)

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
por: Cui, Zhen, et al.
Publicado: (2022)

Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
por: Sun, Shihui, et al.
Publicado: (2021)

Structural basis for neutralization of an anicteric hepatitis associated echovirus by a potent neutralizing antibody
por: Feng, Rui, et al.
Publicado: (2021)

Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method
por: Dou, Yang, et al.
Publicado: (2023)

Antibody cocktail effective against variants of SARS-CoV-2
por: Liang, Kang-Hao, et al.
Publicado: (2021)

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
por: Ku, Zhiqiang, et al.
Publicado: (2021)

Epitope mapping and a cocktail of monoclonal antibodies to achieve full detection coverage of potato virus Y
por: Zhao, Cui‐Ling, et al.
Publicado: (2023)

Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
por: Cao, Yunlong, et al.
Publicado: (2022)

Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
por: Ji, Yun, et al.
Publicado: (2022)

Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
por: Zhang, Chao, et al.
Publicado: (2021)

A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD
por: Liu, Shuo, et al.
Publicado: (2022)

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
por: Du, Shuo, et al.
Publicado: (2021)

Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
por: Ku, Zhiqiang, et al.
Publicado: (2021)

Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth
por: Ku, Zhiqiang, et al.
Publicado: (2022)

Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component
por: Jugler, Collin, et al.
Publicado: (2022)

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
por: Wang, Kang, et al.
Publicado: (2022)

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
por: Hansen, Johanna, et al.
Publicado: (2020)

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
por: Du, Shuo, et al.
Publicado: (2020)

Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails
por: Du, Cong, et al.
Publicado: (2018)

Growth hormone cocktail improves hepatopulmonary syndrome secondary to hypopituitarism: A case report
por: Ji, Wen, et al.
Publicado: (2021)

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
por: Ku, Zhiqiang, et al.
Publicado: (2022)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023)

SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies
por: Chao, Tzu-Yuan, et al.
Publicado: (2017)

A novel plant‐made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS‐CoV‐2 Omicron variant
por: Jugler, Collin, et al.
Publicado: (2022)

In Vivo Efficacy of SYN023, an Anti-Rabies Monoclonal Antibody Cocktail, in Post-Exposure Prophylaxis Animal Models
por: Chao, Tzu-Yuan, et al.
Publicado: (2020)

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
por: Dong, Jinhui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tf1h4ebu2vfi42st4m6v1tl0p0